Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...
biotech stock review

Adding Fluidigm (FLDM) $6.14, to Corona Stock Watch List.

And we have our first 'bounce' candidate of the dip.. LIVE CHART
Inovie, Biotech Stock Review

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Interesting battle brewing! LIVE CHART Inovio shares tumble 8%...
Aphex BioCleanse

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Aphex BioCleanse Systems Enters Agreement with Now Biopharma for Hand Sanitizer Clinical Trial PITTSFORD, N.Y., Aug. 31, 2020 /PRNewswire/ -- Aphex...

Look What We Found. A Bavarian Cure for the Common Cold and CoronaVirus Play!

Adding Bavarian Nordic (BVNRY) $10.50 Adding to CoronaVirus Watch List. Wait Until Robinhood Traders Find Out...

Photos: Aphex BioCleanse Systems.

We had the opportunity to visit the Aphex BioCleanse Systems manufacturing facility on 8-18-2020. Truly impressive seeing tanks readying for shipment, and...

Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).

Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.

Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?

Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com) AKA, you'd have to have your head examined...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...